About Antibiotics

20 June 2026

The safety of nitrofurantoin during pregnancy

According to a large observational study conducted in Norway, the use of nitrofurantoin during pregnancy leads to a slight increase in the risk of birth defects.

19 June 2026

Vancomycin in high doses for the treatment of MRSA infections

The high prevalence of methicillin-resistant Staphylococcus aureus clinical isolates with a high BMC value of vancomycin requires an aggressive empirical dosage of the drug to reach target concentrations of more than 15 μg / ml.

18 June 2026

Fewer physician visits in the United States after introduction of 13-valent pneumococcal conjugate vaccine

In the United States for the period from 2001 to 2011 there is a clear trend to reduce the frequency of pediatrician visits for acute otitis media, especially after the introduction of the 13-valent pneumococcal conjugate vaccine.

17 June 2026

Eradication H. pylori is not indicated for the treatment of patients with functional dyspepsia

Therapy to eradicate H. pylori in patients with functional dyspepsia resistant to conventional therapy and diagnosed with H. pylori infection is no more effective than a simple course of antacid drugs.

16 June 2026

Pharmacokinetics of ceftazidime

The introduction of ceftazidime in patients with severe intra-abdominal infections by continuous intravenous administration is more preferable than its appointment in intermittent mode.

15 June 2026

Daptomycin is effective in the treatment of skin and soft tissue infections.

Daptomycin is effective against infections of the skin and soft tissues caused by strains of Staphylococcus aureus sensitive to methicillin and resistant to methicillin.